by SoP | Jan 20, 2021 | Affect, Research Front |
Targeted neuromodulation tailored to individual patients’ distinctive symptoms is an increasingly common way of correcting misfiring brain circuits in people with epilepsy or Parkinson’s disease. Now, scientists at UC San Francisco’s Dolby Family...
by SoP | Jan 14, 2021 | Affect |
Researchers find that metabolites — small molecules produced by cellular activities — appear to predict risk of recurring depression and may be a new diagnostic tool Researchers at University of California San Diego School of Medicine, in collaboration...